Software Effective Solutions Corp. (SFWJ) Joins Others in Applauding Decision to Reschedule Cannabis

  • Company calls rescheduling a “monumental decision” that signifies a significant shift in U.S. drug policy
  • MedCana CEO notes rescheduling “opens the door to further research, innovation and accessibility, signaling a new era of acceptance and understanding”
  • SFWJ remains committed to advancing the dialogue around cannabis policy and supporting initiatives that promote responsible access and use

Software Effective Solutions (d/b/a MedCana) (OTC: SFWJ) has noted a “historic milestone” as the U.S. Drug Enforcement Administration (“DEA”) moves to reclassify cannabis from Schedule I to Schedule III under the Controlled Substances Act (https://cnw.fm/yNude). The company released an announcement from CEO Jose Gabriel Diaz and observed that the “monumental decision,” based on recommendations from the U.S. Department of Health and Human Services, signifies a significant shift in U.S. drug policy.

“The DEA’s decision to reclassify cannabis is a watershed moment in our nation’s drug policy,” said Diaz. “It opens the door to further research, innovation and accessibility, signaling a new era of acceptance and understanding. MedCana is proud to be part of an industry that advocates for sensible cannabis regulation and equitable access to this vital medicine.”

MedCana joined many companies in responding to the proposed reclassification. “Many applauded the move to Schedule III from Schedule I, which the Associated Press first reported and was later confirmed by a Department of Justice spokesperson in a statement to Cannabis Business Times,” reported the Cannabis Business Times (https://cnw.fm/wW1WX). “Executives from plant-touching companies noted its significance as a historic step toward federal cannabis reform, destigmatization, fairer tax policies for businesses and more research into cannabis’s medical benefits.

“However, many also tempered the celebratory tone and said that there was much more work to be done,” the article continued. “Leaders from industry nonprofit organizations and some lawmakers emphasized their call for the federal government to deschedule cannabis altogether, something they urged after news circulated that the U.S. Department of Health and Human Services (‘HHS’) recommended that the DEA reschedule cannabis in August 2023.”

While there may be work left to do, the initial rescheduling is certainly noteworthy. The announcement from MedCana noted that cannabis has been unjustly categorized as a Schedule I substance alongside heroin and LSD for more than four decades. This was despite the fact that the substance has recognized medical benefits and low potential for abuse. The DEA’s move to reschedule cannabis — a move that will now undergo a period of public comment — is a clear indication of its therapeutic value and aligns with evolving attitudes toward cannabis policy.

In its announcement, MedCana stated that it remains committed to advancing the dialogue around cannabis policy and supporting initiatives that promote responsible use and access to quality cannabis products.

Operating under Software Effective Solutions Corp., MedCana is a pioneer in the integration of technology and agriculture, focusing on the cannabis market and emerging technologies in agriculture. With a vision to revolutionize the industry through innovation, MedCana is dedicated to acquiring and partnering with companies that align with its mission of promoting sustainable and technologically advanced agricultural practices.

For more information, visit the company’s website at www.MedCana.net.

NOTE TO INVESTORS: The latest news and updates relating to SFWJ are available in the company’s newsroom at https://cnw.fm/SFWJ

About CannabisNewsWire

CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Reports Indicate DEA Didn’t Support Marijuana Reclassification

In a secluded section of the U.S. Drug Enforcement Administration (DEA) headquarters known as the 12th-floor “bubble,” director Anne Milgram called a special “marijuana meeting” in March 2024 where she made an unusual request: no one was allowed to take notes. During the meeting, she informed her top deputies that the Biden administration was about to reschedule cannabis as a less-harmful substance, a significant move toward federal legalization that the agency has historically opposed.

Moreover, Milgram disclosed that this reclassification would be handled by the U. S. Department of Justice, not the DEA, and the final decision would be signed by Merrick Garland, the attorney general.

Milgram did not provide a reason for this unprecedented decision, and neither she nor the agency has done so subsequently. However, the plan unfolded exactly as she described, marking the most significant change in U.S. drug policy in half a century, without the DEA’s support.

The DEA has not yet determined the proper schedule for cannabis, according to a statement tucked on page 13 of Garland’s 92-page decision, which was released last Thursday. According to the order, cannabis would be moved from Schedule I, which is more restricted and contains narcotics such as LSD and heroin, to Schedule III, which is less restrictive and includes anabolic steroids and ketamine.

Internal documents show that the agency sent a memo to the DOJ in January, requesting more scientific data to determine if cannabis has approved medical use, a crucial factor for reclassification. However, DOJ attorneys overruled the DEA’s criteria, considering them too restrictive.

Several DEA officers, both past and present, indicated that political considerations could be driving this action. Rather than giving the DEA more time to carry out additional research, they think the DOJ is rushing the recategorization of marijuana to aid Biden in winning support from voters for his reelection campaign.

The DOJ’s engagement in the rescheduling process, in the opinion of retired DEA agent Derek Maltz, puts politics ahead of public safety. He underlined that such choices must be supported by scientific analysis.

Tim Shea, a former administrator of the DEA, echoed this statement, stating that Milgram’s absence from the signature shows her support for the DEA personnel. He voiced concern that the agency’s position had been overridden by political interference, which he said demoralized DEA staff.

The White House didn’t immediately respond, but it has said in the past that Biden is devoted to his pledge made during the campaign that no citizen should be imprisoned for marijuana use. DOJ attorneys supported Garland’s order, pointing out that it resulted from different perspectives held by the HHS and the DEA. Last year, HHS recommended rescheduling cannabis, considering it less harmful than drugs such as heroin and cocaine, and recognizing its effectiveness in treating conditions such as pain and anorexia.

Despite this recommendation, the DEA disagreed, citing the increasing potency of cannabis and the rise in emergency room visits due to its use. The DEA’s concerns were cited multiple times in Garland’s order. The DOJ, however, emphasized that it is legally bound to follow HHS’s medical and scientific determinations on drug classification.

The internal conflict highlights the ongoing debate over the risks of marijuana, despite 38 and 24 states legalizing it for medical and recreational use, respectively. Public support for legalization is also at an all-time high, with 70% of American adults in favor, according to a Gallup poll. Critics argue that the DEA’s stance is outdated and not aligned with public opinion.

The reclassification process, initiated by Biden’s 2022 order for a review, is expected to be lengthy. The DEA will take public comments on the proposal before an administrative judge reviews it and a final rule is published. While federal marijuana prosecutions are rare, its classification as a Schedule III drug would still subject it to regulation.

Milgram has not publicly discussed her position on cannabis. Known for her data-driven and progressive approach, she has historically viewed the legalization debate as less critical compared to the fentanyl crisis. Her recent brief announcement to DEA employees stated only that the agency would comply with posting the notice and attachments on its website, leaving her personal views on the matter unclear.

This revelation that the DEA wasn’t party to the recent announcement to reclassify marijuana federally may be of little consequence to the marijuana industry and its major actors such as Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) as the resulting policy change will require the compliance of all federal agencies.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

The Vermont Cannabis & Hemp Convention by NECANN to Generate Collaborative Deals for the Local Community

Entrepreneurs, traders, enthusiasts, patients, consumers, and service providers of the cannabis industry are invited to attend the Vermont Cannabis & Hemp Convention, a pioneering B2B cannabis industry event on the East Coast. Engaged in organizing conventions since 2014, NECANN believes in bringing together the local cannabis community for better growth and business prospects. The event features the expo, workshops, and programming tracks, in addition to speaker sessions and panel discussions by industry experts. The age limit to attend the conference is 21+.

The NECANN team comprises a group of passionate and talented professionals who design an extensive agenda that involves two days of robust learning, exploration, and networking. The attendees can connect with investors and peers for collaborations and a higher ROI. New businesses as well as seasoned traders exhibit their innovative products and services to leverage the expensive reach of the NECANN platform.

Investors and businesses looking for fresh areas of investment can discover new and exciting products at the exhibition booths. NECANN is a profitable forum for the local community of cultivators, growers, traders, and businesses in Vermont and New England vicinity. The networking connections developed at the NECANN convention will help local retailers expand their reach to earn new businesses and customers.

The convention will feature an impressive line of industry leaders who preside over the speaker sessions at the summit. They will offer their priced insights and strategies on the latest trends in the market. The experts will also talk about the role of AI in shaping consumer experience, the latest regulations, and several other topics of importance. Attendees can customize their schedule and only their bookmarked events.

To know more, please visit https://cnw.fm/S0s5u.

About CannabisNewsWire

CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

Golden Triangle Ventures Inc. (GTVH), Subsidiary Focused on Becoming Leaders in Sector Projected to See Billion-Dollar Growth

  • Recent report notes that the U.S. conferences, concert and event market is on a trajectory of remarkable growth
  • A driving force behind the rapid growth is an increasing demand for unique, immersive experiences
  • Lavish Entertainment is building a reputation for producing high-quality, professional events that offer memorable experiences

With a recent analyst report projecting significant growth in the U.S. conferences, concert and event market, Golden Triangle Ventures (OTC: GTVH) and its entertainment division, Lavish Entertainment, are strengthening their strategic position in the space at an ideal time.

“The United States conferences, concert and event market is on a trajectory of remarkable growth, projected to reach an impressive $660.07 billion by the year 2030,” reported the latest ResearchandMarkets.com report for the industry (https://cnw.fm/wLX9o). The space reportedly reached $339.86 billion in 2022 and is forecast to see a CAGR of 8.65% from 2022 to 2030.

“This sector is currently witnessing a revolutionary phase, with unprecedented developments and transformative changes,” the report continued. “Events have become powerful platforms that bring people together for various purposes, including corporate development, entertainment, celebration, and community engagement. From conferences and business seminars to fundraisers, music performances, sports events, festivals, trade exhibitions, and product launches, a wide array of events are immensely popular across the nation. . . .

“The conference, concert and event sector in the United States is vibrant and diverse, comprising a multitude of activities catering to diverse interests and demographics,” the report stated. “Beyond just entertainment, this industry plays a crucial role in fostering economic development, generating wealth and creating employment opportunities.”

ResearchandMarkets.com noted that a significant driving force behind the space’s rapid growth is an increasing demand for unique and immersive experiences. Event organizers continuously strive to innovate and exceed boundaries to provide fascinating interactions for attendees. “From interactive exhibitions and immersive marketing activations to live performances and gourmet experiences, events are designed to amaze and engage people in extraordinary ways. As the thirst for exceptional experiences grows, the events market in the United States is set to flourish in the coming years.”

Exceptional events are exactly what Lavish Entertainment is dedicated to providing. A wholly owned subsidiary of Golden Triangle Ventures, Lavish Entertainment is currently headquartered in Las Vegas and is committed to producing high-quality, professional events that provide immersive, memorable experiences (https://cnw.fm/EJWX3). In addition to becoming nationally recognized in concert production, the company is currently developing a flagship entertainment complex called Destino Ranch, an outdoor music and festival venue, immersive art installation, tourist attraction, and destination center — all in one location.

Golden Triangle Ventures is a multifaceted consulting company that operates as a parent business pursuing ventures in the health, entertainment and technology sectors, as well as in other areas that provide synergistic value to these three core divisions. The company aims to purchase, acquire and/or joint venture with established entities within these areas of business. The goods and services represented are driven by innovators who have passion and commitment in these marketplaces. The company plans to utilize relationships and create a platform for new and existing businesses to strengthen their products and/or services. The three points of the Golden Triangle exclusively represent the three sectors the company aims to do business in.

For more information, visit the company’s website at www.GoldenTriangleInc.com.

NOTE TO INVESTORS: The latest news and updates relating to GTVH are available in the company’s newsroom at https://cnw.fm/GTVH

About CannabisNewsWire

CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Marijuana Research Hurdles Could Remain Despite Federal Rescheduling

The Biden administration’s decision to reclassify cannabis as a less-harmful drug might ease some research challenges, though scientists caution that obstacles will persist. Ziva Cooper, director of the UCLA Center for Marijuana and Cannabinoids, described this moment as historically significant but expressed cautious optimism about the actual implementation of these changes.

Although many Americans now live in states where marijuana is legal, federal restrictions have historically constrained research into its effects and applications. Researchers who have long studied marijuana believe this reclassification could boost funding and interest in research. However, they acknowledge that regulatory and logistical issues may still dampen enthusiasm.

Traci Toomey, who heads the University of Minnesota’s Marijuana Research Center, echoed Cooper’s sentiments. She noted that while some research opportunities might open up, these opportunities will not be entirely unrestricted.

Last week, the U.S. Department of Justice formally recommended reclassifying cannabis as a Schedule III substance, which recognizes its potential medical benefits and aligns its classification with drugs such as codeine-infused Tylenol, testosterone and ketamine. This shift would not legalize cannabis at the federal level but would remove it from the same category as LSD and heroin, thus reducing some of the restrictions around it.

Recently, an assessment by the U.S. Department of Health and Human Services noted that there was some reliable scientific evidence supporting the use of cannabis as a treatment for specific ailments. Nonetheless, some detractors contend that there is insufficient proof to support its medicinal application.

The federal government’s finalization of this reclassification will probably lower certain barriers to study. It will be easier for academics to obtain federal research licenses, and researchers won’t need to store cannabis in costly, highly secure facilities. Moreover, the U.S. Drug Enforcement Administration would no longer impose quotas on cannabis production for research purposes.

This could make hospitals, universities and even government agencies more willing to support clinical trials involving marijuana, according to Will Humble, executive director of the Arizona Public Health Association.

However, the impact of FDA regulations on cannabis research remains uncertain. While the FDA normally approves Schedule III drugs, it has not yet approved cannabis for any treatment, although it is commonly used for pain treatment, hunger stimulation and nausea control following chemotherapy.

Furthermore, rescheduling marijuana will not immediately increase the number of FDA-approved facilities where researchers can obtain the drug.

Valerie Ahanonu, head of the University of Utah’s Center for Medical Marijuana Research, highlighted that even years after the legalization of hemp-derived CBD, research remains difficult due to sourcing issues that meet federal standards. Ahanonu stressed the complexity and extensive bureaucratic procedures involved, making it uncertain how much the reclassification will genuinely enhance research opportunities.

Despite these challenges, the potential for expanded research and a greater understanding of marijuana’s medical applications remains promising, and marijuana enterprises such as Aurora Cannabis Corp. (NASDAQ: ACB) (TSX: ACB) are likely to applaud every policy change that moves cannabis a step away from the existing prohibitive restrictions at the federal level.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

10th Annual CWCBExpo To Offer News on Latest Trends & Ideas In The Cannabis Industry

As New York and the Tri-State area are being touted as one of the largest cannabis hubs in recent times, the CWCBExpo is perfectly timed to bring together the cannabis industry in New York. A premier B2B expo on the East Coast, the CWCBExpo, June 5-6 at the Javits Center in New York, brings in two days of networking events and learning sessions by prominent influencers in the industry. The event will witness industry leaders, investors, influencers, business executives, dispensary owners, educators, medical practitioners, and some of the brightest minds in the cannabis and hemp spectrum.

The CWCBExpo has been hosting events since 2014, offering the cannabis community a common forum for networking and education. Attendees connect with the industry veterans and peers to engage, learn, and collaborate with the best cannabis business opportunities in the market.

Eminent personas from the cannabis spectrum will conduct keynote/speaker sessions discussing some of the most pivotal topics of the cannabis industry, including Josh Kesselman, founder and CEO of HBI International/RAW Rolling Papers. They will share in-depth insights, and speak about the discoveries and latest innovations in the cannabis market.

Several cannabis and hemp companies and service providers will display their products and innovative ideas at the exhibitor booths. The CWCBExpo offers a phenomenal platform for exhibitors to showcase their products and services amongst the top businesses, retailers, and investors of the cannabis community. Investors and businessmen looking for fresh avenues of investment can discover tremendous talent at these exhibitor booths.

Get industry updates, connect with potential investors and collaborators, and leverage the best business opportunities this event has to offer. Apart from the educational sessions and exhibitor displays, the expo hosts several networking opportunities to the attendees including a B2B Rooftop Networking Bash, Women in Cannabis Business Luncheon, Industry Yacht Party, and the NYCRA’s After Party.

To learn more please visit https://cnw.fm/rVsCf https://cnw.fm/qfcOX.

About CannabisNewsWire

CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Marijuana Companies Ask Court to Stream Online Proceedings of Case Against Federal Prohibition

Leading cannabis companies are urging a federal court to permit the public to attend a hearing virtually in a lawsuit where the companies are requesting protection for in-state marijuana activities from federal interference. The U.S. Department of Justice has stated it holds “no stance” on this request.

The hearing will take place before the United States District Court for the Western Division of the District of Massachusetts. The plaintiffs’ attorneys highlighted in a motion that the disagreement raises issues of public interest. They reported receiving a lot of requests from the media to watch the hearing online, as most can’t be present in person.

Further, they argue that permitting remote access to the hearing will not prejudice any parties involved. They suggest that access by phone or video conference would be adequate. They also mentioned that they consulted with the defendant’s counsel, who confirmed that the defendant has no stance on the motion.

The lawsuit, titled Canna Provisions vs. Garland, is spearheaded by Verano Holdings Corp., a multistate cannabis operator, alongside Massachusetts-based marijuana companies Wiseacre Farm and Canna Provisions as well as Gyasi Sellers, the CEO of Treevit.

Leading the lawsuit is David Boies, who has previously represented clients such as former vice president Al Gore, the DOJ and plaintiffs in the lawsuit that resulted in the repeal of California’s same-sex marriage statute.

In their lawsuit, the companies argue that the federal prohibition of cannabis lacks justification, especially given the widespread legalization of cannabis in states and the federal government’s generally noninterventionist stance on the matter.

Last month, the plaintiffs requested oral arguments, a request granted by Judge Mark G. Mastroianni, an appointee of President Barak Obama. In response, the DOJ maintained its neutral position.

Central to the case is whether in-state marijuana activity impacts interstate commerce. The federal government contends that marijuana legalization draws tourists from other states, thereby affecting interstate commerce. In a recent filing, the DOJ contended that it makes sense to conclude that Massachusetts’s legal cannabis market stimulates marijuana tourism, a distinct type of cannabis-related interstate commerce.

The DOJ’s brief referenced a Supreme Court decision from decades ago, affirming Congress’s jurisdiction to regulate establishments attracting out-of-state tourists, even if the transactions occur entirely within the state. Conversely, the plaintiffs argue that the Commerce Clause of the Constitution should not allow the DOJ to interfere in activities legal within state borders, as the state itself regulates these.

The recent motion follows an announcement by President Joseph Biden that his administration is formally reclassifying cannabis. A proposal to place marijuana in Schedule III is set to be published in the Federal Register soon.

The planned regulation change was approved by Attorney General Merrick Garland, one of the main defendants in this case. However, rescheduling marijuana would not equate to federal legalization, and it appears unlikely that this rulemaking will impact the DOJ’s stance in the ongoing court case.

Cannabis industry actors such as Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ) await the completion of the rulemaking process so that they can map out their future plans accordingly.

NOTE TO INVESTORS: The latest news and updates relating to Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ) are available in the company’s newsroom at https://cnw.fm/SFWJ

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

Software Effective Solutions Corp. (SFWJ) Subsidiary Expands Global Footprint, Becomes Leading Infrastructure Supplier for Colombia’s Top Flower Producers

  • MedCana subsidiary is expanding reach both domestically and internationally
  • Company is strengthening support, sales operations through international partnerships
  • Eko2o is at the forefront of providing innovative agricultural technology and infrastructure solutions

Eko2o S.A.S., a subsidiary of Software Effective Solutions (d/b/a MedCana) (OTC: SFWJ), is experiencing significant growth and success, as evidenced by recent news that it has become a key infrastructure supplier for some of Colombia’s largest flower producers (https://cnw.fm/PI8yO). In addition, Eko2o is strengthening its support and sales operations through international partnerships and collaborations, including with Danziger International.

“Our solutions stand out in the market, and we are delighted to witness our company’s growth as we expand our reach both domestically and internationally,” said Eko2o CEO Juan Ricardo Velez. In the announcement, the company noted that it has solidified its reputation as a leading provider of greenhouse infrastructure and agricultural technology.

Earlier this year, the company entered into a “pivotal” agreement with Danziger Colombia (https://cnw.fm/YxwtB). The agreement is projected to generate between $2.5 million and $3 million in revenue over the next three years and represents the commitment both organizations have to innovative agricultural practices. The agreement noted that Eko2o would provide greenhouse infrastructure services, irrigation products and technology and other technologies related to Danziger’s flower operations in Colombia.

That initial agreement led to Eko2o’s expanding collaboration with Danziger International, marking a significant step in Eko2o’s strategy to increase its global footprint, leveraging its expertise to support one of the flower industry’s most respected names. “This collaboration is expected to boost Eko2o’s visibility on the international stage and foster new opportunities in global markets,” the company noted in the announcement.

Eko2o’s commitment to excellence and innovation continues to attract the attention of major industry players, contributing to Colombia’s reputation as a leader in floriculture and agricultural technology. The company is at the forefront of providing innovative agricultural technology and infrastructure solutions. As a leading provider in Colombia, Eko2o is dedicated to enhancing agricultural productivity and sustainability through cutting-edge technologies and services that support farmers and agricultural businesses in achieving higher yields and operational efficiency.

MedCana, operating under Software Effective Solutions Corp., is a pioneer in the integration of technology and agriculture, focusing on the cannabis market and emerging technologies in agriculture. With a vision to revolutionize the industry through innovation, MedCana is dedicated to acquiring and partnering with companies that align with its mission of promoting sustainable and technologically advanced agricultural practices.

For more information, visit the company’s website at www.MedCana.net.

NOTE TO INVESTORS: The latest news and updates relating to SFWJ are available in the company’s newsroom at https://cnw.fm/SFWJ

About CannabisNewsWire

CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

Golden Triangle Ventures Inc. (GTVH) Subsidiary Shares New Business Model Based on Key Pillars to Ensure Success

  • Strategic four-pillar business model provides essential piece of Lavish Entertainment’s mission to create an industry-leading entertainment business
  • New model “represents a bold step forward in our journey to develop Lavish Entertainment into a staple in the entertainment industry,” states CEO
  • The company plans to develop, acquire operations in each of plan’s four areas

At the core of Golden Triangle Ventures’ (OTC: GTVH) purpose of pursuing ventures in the health, entertainment and technology sectors lies its focus on vertical integration to cut costs and maximize margins. One of the company’s newest ventures — Lavish Entertainment, its entertainment division — embodies this focus, as evidenced by its recently released four-pillar business model (https://cnw.fm/jQ33l).

According to GTVH, this strategic framework provides an essential piece of Lavish Entertainment’s mission to create an industry-leading entertainment business. The company’s new model includes key foundational elements — logistics, staffing, equipment and production — that were carefully identified and organized to complement each other and ensure seamless operations across all facets of the company.

“We are thrilled to introduce our innovative four-pillar business model, which represents a bold step forward in our journey to develop Lavish Entertainment into a staple in the entertainment industry,” said Marco Antonio Moreno, president and COO at Lavish Entertainment. “We look forward to showing our shareholders how this new business model will unfold.”

With its new business model as a backdrop, Lavish Entertainment plans to develop and acquire operations in each of the four areas of the plan. Specifically, the announcement noted that “effective logistics are the backbone of any successful entertainment operation” and that “by establishing a dedicated logistics business, Lavish Entertainment can streamline its event-planning processes, ensure seamless coordination of resources and services, minimize delays, and enhance overall efficiency.”

In addition, the company’s staffing, or talent and manpower, are indispensable assets in the entertainment industry. “Whether it’s skilled technicians, event coordinators or guest services personnel, assembling the right team is essential for delivering memorable experiences,” the company stated. “Lavish Entertainment’s staffing division will focus on recruiting, training and managing a diverse array of talent to meet the demands of its multifaceted operations.”

Equipment is equally important to Lavish Entertainment’s corporate vision, which calls for cutting-edge equipment and state-of-the-art technology, both indispensable for creating an immersive entertainment experience. The company’s comprehensive strategy, the announcement noted, will “focus on acquiring, maintaining and upgrading a vast equipment inventory to support a diverse range of productions and events. Top-tier equipment will allow Lavish Entertainment to push the boundaries of creativity and innovation, deliver memorable experiences, and leave forever lasting impressions.”

Production is the final pillar in the business model. “Whether it’s designing captivating stage sets, crafting compelling narratives or executing seamless live performances, the art of production is paramount for success,” the company stated. “The level of expertise in production makes the difference between uninspired and unforgettable. It is essential for bringing creative visions to life and is a critical pillar to advance Lavish Entertainment forward.”

The company noted that this strategic business model is specifically applicable to the company’s flagship project: Destino Ranch. Strategically located to be accessible to tens of thousands of visitors a day, Destino Ranch is destined to become a modern art and music festival mecca. The one-of-a-kind location will combine the natural beauty of the Mojave Desert with an immersive, world-class art installation gallery and a large-scale music venue to become an international destination that rivals Coachella and other well-known festival sites.

Golden Triangle Ventures is a multifaceted consulting company that operates as a parent business pursuing ventures in the health, entertainment and technology sectors, along with other areas that provide synergistic value to these three core divisions. The company aims to purchase, acquire and/or joint venture with established entities within these areas of business. The goods and services represented are driven by innovators who have passion and commitment in these marketplaces. The company plans to utilize relationships and create a platform for new and existing businesses to strengthen their products and/or services. The three points of the Golden Triangle exclusively represent the three sectors the company aims to do business in.

For more information, visit the company’s website at www.GoldenTriangleInc.com.

NOTE TO INVESTORS: The latest news and updates relating to GTVH are available in the company’s newsroom at https://cnw.fm/GTVH

About CannabisNewsWire

CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Biden Welcomes Marijuana Reclassification, Slams ‘Failed Approach’


The U.S. Department of Justice (DOJ) has moved to reschedule marijuana as a less-hazardous narcotic, marking the most substantial drug-policy reform in the nation in more than half a century. President Joseph Biden celebrated the move as a crucial step toward correcting historical injustices.

This marks a notable shift for President Biden, who, 30 years ago, was instrumental in crafting stringent crime legislation that is now a source of political contention. This change could bolster Biden’s appeal among younger voters, a demographic crucial for his re-election campaign.

The new proposal, announced on May 16, 2024, stops short of fully legalizing recreational cannabis, which is currently legal in 24 states and DC. Additionally, 38 states have legalized cannabis for medical use.

“Too many lives have been disrupted by our failed marijuana policies,” Biden stated on X. “I’m dedicated to rectifying these historical wrongs,” he added.

The proposal would reclassify cannabis from the restrictive Schedule I of the Controlled Substances Act (CSA) to Schedule III. This change would mean that the federal administration no longer categorizes cannabis with highly dangerous and addictive drugs such as LSD, ecstasy and heroin.

Substances listed under Schedule III are considered to have a lower-to-moderate potential for abuse. Examples of such drugs include testosterone, anabolic steroids and ketamine.

Cannabis has remained classified as a Schedule I substance ever since Congress approved the CSA in 1970. Reclassifying it could significantly benefit the legal marijuana sector by improving access to conventional banking services and attracting external investments.

The policy change could also be a major help to Biden’s attempts to mobilize support from minority and young voters, especially amid widespread discontent over issues such as the conflict in Gaza.

Biden wrote the 1994 crime legislation while he was a senator, which is sometimes faulted for mass incarceration for drug charges, especially involving Blacks. In his 2020 presidential campaign, Biden committed to decriminalizing cannabis use, arguing that no one ought to be imprisoned for small amounts’ possession or usage.

However, he has not supported complete legalization. Instead, his administration has issued mass pardons twice for individuals with federal convictions for marijuana possession.

Referencing his prior actions, Biden reaffirmed on X that no one should be jailed just for possessing or using cannabis. He said, “At the moment, cannabis is ranked higher than methamphetamine and fentanyl, the two drugs fueling the U.S.’s overdose crisis. That disparity is incomprehensible.”

The recent proposal being a detailed approval process, starting with a 60-day public comment period before the change can be enacted.

Any step taken to ease the strict marijuana laws at the federal level is likely to be welcomed by the entire industry, such as Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF), as it would be chipping away at decades of prohibition.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN